Clinical Trials on Solid Tumor in New Zealand
Total 3349 results
-
Kadmon, a Sanofi CompanyTerminated
-
Eli Lilly and CompanyCompleted
-
Zai Lab (Hong Kong), Ltd.Merck Sharp & Dohme LLC; Zai Biopharmaceutical (Shanghai) Co., Ltd.RecruitingMalignant Solid TumorUnited States, Spain
-
BeiGeneRecruitingAdvanced Solid TumorAustralia
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Genentech, Inc.Completed
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompleted
-
Shanghai YingLi Pharmaceutical Co. Ltd.Yingli Pharma US, IncRecruitingAdvanced Solid TumorUnited States
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid TumorAustralia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Testicular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Retinoblastoma | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Qualigen Theraputics, Inc.Translational Drug DevelopmentRecruiting
-
Roswell Park Cancer InstituteAbbottCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Incyte CorporationActive, not recruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsFrance, Spain, United States, China, United Kingdom, Lithuania, Germany, Ukraine, Finland, Italy, Belgium, Australia, Bulgaria, Latvia, New Zealand, Poland
-
Memorial Sloan Kettering Cancer CenterRecruitingMalignant Solid TumorsUnited States
-
Shanghai Best-Link Bioscience, LLCRecruitingAdvanced Solid TumorChina, Australia
-
Onconova Therapeutics, Inc.TerminatedNeoplasms | Advanced Solid TumorUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BioNTech SERecruiting
-
Stingray TherapeuticsRecruitingAdvanced / Metastatic Solid TumorAustralia
-
Atridia Pty Ltd.Completed
-
BioNTech SEActive, not recruitingSolid TumorUnited States, Spain
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorUnited States
-
Kite, A Gilead CompanyTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedSolid TumorsUnited States
-
Roswell Park Cancer InstituteCleveland BioLabs, Inc.CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Yale UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Yale UniversityNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Aprea TherapeuticsRecruitingAdvanced Solid TumorUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Genentech, Inc.CompletedSolid TumorUnited States, Korea, Republic of, Spain, France
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedRecurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS MalignanciesUnited States
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Montclair State UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Repare TherapeuticsRoche Pharma AGRecruitingAdvanced Solid Tumor, AdultUnited States
-
OmicoHoffmann-La Roche; The George Institute for Global Health, AustraliaRecruitingSolid Tumor, AdultAustralia
-
Bristol-Myers SquibbTerminatedSolid TumorUnited States, Finland